{"id":973104,"date":"2026-06-17T08:34:03","date_gmt":"2026-06-17T12:34:03","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/cerus-to-showcase-new-evidence-innovation-and-global-experience-with-the-intercept-blood-system-at-the-39th-international-isbt-congress\/"},"modified":"2026-06-17T08:34:03","modified_gmt":"2026-06-17T12:34:03","slug":"cerus-to-showcase-new-evidence-innovation-and-global-experience-with-the-intercept-blood-system-at-the-39th-international-isbt-congress","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/cerus-to-showcase-new-evidence-innovation-and-global-experience-with-the-intercept-blood-system-at-the-39th-international-isbt-congress\/","title":{"rendered":"Cerus to Showcase New Evidence, Innovation and Global Experience with the INTERCEPT Blood System at the 39th International ISBT Congress"},"content":{"rendered":"<p>        <!--.bwalignc { text-align: center; list-style-position: inside }\n.bwlistcircle { list-style-type: circle }\n.bwlistdisc { list-style-type: disc }\n.bwuline { text-decoration: underline }body {font:normal small Arial,Helvetica,sans-serif;color:#000;background-color:#fff;padding:24px;margin:0;} a img {border:0;} h3 {font-size:medium;color:#000;margin:0 0 1em 0; text-align:center;}-->  <\/p>\n<p class=\"bwalignc\"><b>Cerus to Showcase New Evidence, Innovation and Global Experience with the INTERCEPT Blood System at the 39th International ISBT Congress<\/b><\/p>\n<p>CONCORD, Calif.&#8211;(<a href=\"http:\/\/www.businesswire.com\">BUSINESS WIRE<\/a>)&#8211;<br \/>\nCerus Corporation (Nasdaq: CERS) announced today a company-sponsored lunch symposium and a selection of abstracts at the International Society of Blood Transfusion (ISBT) 39<sup>th<\/sup> International ISBT Congress, taking place in Kuala Lumpur, Malaysia, from June 20 through June 24, 2026. Transfusion medicine experts and professionals from around the world are expected to attend the ISBT Congress.<\/p>\n<p>\n\u201cWe look forward to highlighting how blood centers around the world are leveraging INTERCEPT technology to strengthen blood safety, improve operational efficiency and enhance patient care,\u201d said Christian Boutemy, vice president, international commercial operations at Cerus. \u201cThis year\u2019s abstracts reflect the growing body of evidence supporting the INTERCEPT Blood System, alongside valuable real-world experiences from blood centers across Asia. The presentations showcase innovations intended to help optimize operations, including reduced processing times with the LED-based INT200 illuminator and inventory management advantages associated with extended platelet shelf-life, as demonstrated by experience from Thailand. Importantly, an abstract from China draws attention to persistent bacterial contamination risks in platelet components and reinforces the value of a proactive pathogen-inactivation strategy in one of the world\u2019s largest transfusion markets.\u201d<\/p>\n<p>\nThe following is a list of selected presentations and abstracts of interest for Cerus. All presentation times are listed in Malaysian Time (MYT \u2013 UTC+8).<\/p>\n<p><b><span class=\"bwuline\">Oral Presentation<\/span><\/b><\/p>\n<ul class=\"bwlistdisc\">\n<li>\nSunday, June 21, 2026, 12:45\u201313:45 \u2013 Cerus symposium<br \/>\n<br \/><b>Pathogen Inactivation: The Proactive Choice to Improve Blood Safety<\/b><\/li>\n<li>\nChair: Pimpun Kitpoka, Thailand<\/p>\n<\/li>\n<li>\nPresentations:<\/p>\n<ul class=\"bwlistcircle\">\n<li>\nBlood safety &#8211; Miles to go, before we sleep \u2013 Dr. Albert Farrugia<\/p>\n<\/li>\n<li>\nINTERCEPT: Unmatched evidence and Proven patient benefits \u2013 Dr. Richard Benjamin<\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p><b><span class=\"bwuline\">Poster Presentations<br \/>\n<br \/><\/span><\/b>Poster-Session: Monday, June 22, 2026, 17:15\u201318:45 hours<\/p>\n<p>\nSelect Posters of Interest<\/p>\n<ul class=\"bwlistdisc\">\n<li>\nP363 &#8211; Preserved Fibrinogen Recovery and Stability of Low Plasma Volume Pathogen Reduced Cryoprecipitated Fibrinogen Complex. M. Gatmaitan, A. Paez, Y. Luo <i>et al<\/i><\/li>\n<li>\nP373 &#8211; Reduction in Compound Adsorption Device Exposure Time for Pathogen Inactivated Platelet Components Treated With Amotosalen and an LED-Based Illumination Device. B. Dillon, A. Bernal, S. Crawford <i>et al<\/i><\/li>\n<li>\nP370 &#8211; Introduction of Pathogen-Reduced Double-Dose Apheresis Platelets in a Tertiary Teaching Hospital in Thailand \u2013 Impact on Component Characteristics and Clinical Use. S. Khuenkham, N. Neeranatpaiboon, M. Picard-Maureau <i>et al<\/i><\/li>\n<li>\nP376 &#8211; Amotosalen\/UVA Inactivation of TTI-Associated Bacteria in Platelet Components. M. Krath, A. Engelhaupt, P. Nahata <i>et al<\/i><\/li>\n<li>\nP478 &#8211; Bacterial Contamination of Platelet Concentrates in China. H. Weidong, C. Yuanfeng, X. Junfeng <i>et al<\/i><\/li>\n<\/ul>\n<p>\nThe full program of Cerus-related abstracts can be found here: https:\/\/interceptbloodsystem.com\/wp-content\/uploads\/2026\/06\/2026_ISBT_AbstractBook.pdf.<\/p>\n<p><b>ABOUT CERUS<\/b><\/p>\n<p>\nCerus Corporation is dedicated solely to safeguarding the world\u2019s blood supply and aims to become the preeminent global blood products company. Headquartered in Concord, California, the company develops and supplies vital technologies and pathogen-protected blood components to blood centers, hospitals, and ultimately patients who rely on safe blood. The INTERCEPT Blood System for platelets and plasma is available globally and remains the only pathogen reduction system with both CE mark and FDA approval for these two blood components. In the U.S., the INTERCEPT Blood System for Cryoprecipitation is approved for the production of Pathogen Reduced Cryoprecipitated Fibrinogen Complex (commonly referred to as INTERCEPT Fibrinogen Complex), a therapeutic product for the treatment and control of bleeding, including massive hemorrhage, associated with fibrinogen deficiency. The INTERCEPT red blood cell system is under regulatory review in Europe, and in late-stage clinical development in the U.S. For more information about Cerus, visit www.cerus.com and follow us on LinkedIn.<\/p>\n<p>\nCerus, INTERCEPT, and the Cerus logo are trademarks of Cerus Corporation.<\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260617460945r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" style=\"width:0;height:0\" \/><span class=\"bwct31415\" \/><\/p>\n<p id=\"mmgallerylink\"><span id=\"mmgallerylink-phrase\">View source version on businesswire.com: <\/span><span id=\"mmgallerylink-link\"><a href=\"https:\/\/www.businesswire.com\/news\/home\/20260617460945\/en\/\" rel=\"nofollow\">https:\/\/www.businesswire.com\/news\/home\/20260617460945\/en\/<\/a><\/span><\/p>\n<p>\nTim Lee \u2013 Head of Investor Relations<br \/>\n<br \/>Cerus Corporation<br \/>\n<br \/>ir@cerus.com<br \/>\n<br \/>925-288-6128<\/p>\n<p><b>KEYWORDS:<\/b> North America United States Asia Pacific Malaysia Southeast Asia California<\/p>\n<p><b>INDUSTRY KEYWORDS:<\/b> Biotechnology Medical Supplies Surgery General Health Health Medical Devices Hospitals Health Technology<\/p>\n<p><b>MEDIA:<\/b><\/p>\n<table cellpadding=\"3\" cellspacing=\"3\">\n<tr>\n<td><font face=\"Arial\" size=\"2\"><b>Logo<\/b><\/font><\/td>\n<\/tr>\n<tr>\n<td><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20260617460945\/en\/724993\/3\/cerus_210x60.jpg\" alt=\"Logo\" \/><\/td>\n<\/tr>\n<tr>\n<td><font face=\"Arial\" size=\"2\"><\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"<p>Cerus to Showcase New Evidence, Innovation and Global Experience with the INTERCEPT Blood System at the 39th International ISBT Congress CONCORD, Calif.&#8211;(BUSINESS WIRE)&#8211; Cerus Corporation (Nasdaq: CERS) announced today a company-sponsored lunch symposium and a selection of abstracts at the International Society of Blood Transfusion (ISBT) 39th International ISBT Congress, taking place in Kuala Lumpur, Malaysia, from June 20 through June 24, 2026. Transfusion medicine experts and professionals from around the world are expected to attend the ISBT Congress. \u201cWe look forward to highlighting how blood centers around the world are leveraging INTERCEPT technology to strengthen blood safety, improve operational efficiency and enhance patient care,\u201d said Christian Boutemy, vice president, international commercial operations at Cerus. \u201cThis year\u2019s abstracts reflect the &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/cerus-to-showcase-new-evidence-innovation-and-global-experience-with-the-intercept-blood-system-at-the-39th-international-isbt-congress\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Cerus to Showcase New Evidence, Innovation and Global Experience with the INTERCEPT Blood System at the 39th International ISBT Congress&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-973104","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Cerus to Showcase New Evidence, Innovation and Global Experience with the INTERCEPT Blood System at the 39th International ISBT Congress - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/cerus-to-showcase-new-evidence-innovation-and-global-experience-with-the-intercept-blood-system-at-the-39th-international-isbt-congress\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Cerus to Showcase New Evidence, Innovation and Global Experience with the INTERCEPT Blood System at the 39th International ISBT Congress - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Cerus to Showcase New Evidence, Innovation and Global Experience with the INTERCEPT Blood System at the 39th International ISBT Congress CONCORD, Calif.&#8211;(BUSINESS WIRE)&#8211; Cerus Corporation (Nasdaq: CERS) announced today a company-sponsored lunch symposium and a selection of abstracts at the International Society of Blood Transfusion (ISBT) 39th International ISBT Congress, taking place in Kuala Lumpur, Malaysia, from June 20 through June 24, 2026. Transfusion medicine experts and professionals from around the world are expected to attend the ISBT Congress. \u201cWe look forward to highlighting how blood centers around the world are leveraging INTERCEPT technology to strengthen blood safety, improve operational efficiency and enhance patient care,\u201d said Christian Boutemy, vice president, international commercial operations at Cerus. \u201cThis year\u2019s abstracts reflect the &hellip; Continue reading &quot;Cerus to Showcase New Evidence, Innovation and Global Experience with the INTERCEPT Blood System at the 39th International ISBT Congress&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/cerus-to-showcase-new-evidence-innovation-and-global-experience-with-the-intercept-blood-system-at-the-39th-international-isbt-congress\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-06-17T12:34:03+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260617460945r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cerus-to-showcase-new-evidence-innovation-and-global-experience-with-the-intercept-blood-system-at-the-39th-international-isbt-congress\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cerus-to-showcase-new-evidence-innovation-and-global-experience-with-the-intercept-blood-system-at-the-39th-international-isbt-congress\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Cerus to Showcase New Evidence, Innovation and Global Experience with the INTERCEPT Blood System at the 39th International ISBT Congress\",\"datePublished\":\"2026-06-17T12:34:03+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cerus-to-showcase-new-evidence-innovation-and-global-experience-with-the-intercept-blood-system-at-the-39th-international-isbt-congress\\\/\"},\"wordCount\":664,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cerus-to-showcase-new-evidence-innovation-and-global-experience-with-the-intercept-blood-system-at-the-39th-international-isbt-congress\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20260617460945r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cerus-to-showcase-new-evidence-innovation-and-global-experience-with-the-intercept-blood-system-at-the-39th-international-isbt-congress\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cerus-to-showcase-new-evidence-innovation-and-global-experience-with-the-intercept-blood-system-at-the-39th-international-isbt-congress\\\/\",\"name\":\"Cerus to Showcase New Evidence, Innovation and Global Experience with the INTERCEPT Blood System at the 39th International ISBT Congress - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cerus-to-showcase-new-evidence-innovation-and-global-experience-with-the-intercept-blood-system-at-the-39th-international-isbt-congress\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cerus-to-showcase-new-evidence-innovation-and-global-experience-with-the-intercept-blood-system-at-the-39th-international-isbt-congress\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20260617460945r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"datePublished\":\"2026-06-17T12:34:03+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cerus-to-showcase-new-evidence-innovation-and-global-experience-with-the-intercept-blood-system-at-the-39th-international-isbt-congress\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cerus-to-showcase-new-evidence-innovation-and-global-experience-with-the-intercept-blood-system-at-the-39th-international-isbt-congress\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cerus-to-showcase-new-evidence-innovation-and-global-experience-with-the-intercept-blood-system-at-the-39th-international-isbt-congress\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20260617460945r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20260617460945r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cerus-to-showcase-new-evidence-innovation-and-global-experience-with-the-intercept-blood-system-at-the-39th-international-isbt-congress\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Cerus to Showcase New Evidence, Innovation and Global Experience with the INTERCEPT Blood System at the 39th International ISBT Congress\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Cerus to Showcase New Evidence, Innovation and Global Experience with the INTERCEPT Blood System at the 39th International ISBT Congress - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/cerus-to-showcase-new-evidence-innovation-and-global-experience-with-the-intercept-blood-system-at-the-39th-international-isbt-congress\/","og_locale":"en_US","og_type":"article","og_title":"Cerus to Showcase New Evidence, Innovation and Global Experience with the INTERCEPT Blood System at the 39th International ISBT Congress - Market Newsdesk","og_description":"Cerus to Showcase New Evidence, Innovation and Global Experience with the INTERCEPT Blood System at the 39th International ISBT Congress CONCORD, Calif.&#8211;(BUSINESS WIRE)&#8211; Cerus Corporation (Nasdaq: CERS) announced today a company-sponsored lunch symposium and a selection of abstracts at the International Society of Blood Transfusion (ISBT) 39th International ISBT Congress, taking place in Kuala Lumpur, Malaysia, from June 20 through June 24, 2026. Transfusion medicine experts and professionals from around the world are expected to attend the ISBT Congress. \u201cWe look forward to highlighting how blood centers around the world are leveraging INTERCEPT technology to strengthen blood safety, improve operational efficiency and enhance patient care,\u201d said Christian Boutemy, vice president, international commercial operations at Cerus. \u201cThis year\u2019s abstracts reflect the &hellip; Continue reading \"Cerus to Showcase New Evidence, Innovation and Global Experience with the INTERCEPT Blood System at the 39th International ISBT Congress\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/cerus-to-showcase-new-evidence-innovation-and-global-experience-with-the-intercept-blood-system-at-the-39th-international-isbt-congress\/","og_site_name":"Market Newsdesk","article_published_time":"2026-06-17T12:34:03+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260617460945r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cerus-to-showcase-new-evidence-innovation-and-global-experience-with-the-intercept-blood-system-at-the-39th-international-isbt-congress\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cerus-to-showcase-new-evidence-innovation-and-global-experience-with-the-intercept-blood-system-at-the-39th-international-isbt-congress\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Cerus to Showcase New Evidence, Innovation and Global Experience with the INTERCEPT Blood System at the 39th International ISBT Congress","datePublished":"2026-06-17T12:34:03+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cerus-to-showcase-new-evidence-innovation-and-global-experience-with-the-intercept-blood-system-at-the-39th-international-isbt-congress\/"},"wordCount":664,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cerus-to-showcase-new-evidence-innovation-and-global-experience-with-the-intercept-blood-system-at-the-39th-international-isbt-congress\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260617460945r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cerus-to-showcase-new-evidence-innovation-and-global-experience-with-the-intercept-blood-system-at-the-39th-international-isbt-congress\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/cerus-to-showcase-new-evidence-innovation-and-global-experience-with-the-intercept-blood-system-at-the-39th-international-isbt-congress\/","name":"Cerus to Showcase New Evidence, Innovation and Global Experience with the INTERCEPT Blood System at the 39th International ISBT Congress - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cerus-to-showcase-new-evidence-innovation-and-global-experience-with-the-intercept-blood-system-at-the-39th-international-isbt-congress\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cerus-to-showcase-new-evidence-innovation-and-global-experience-with-the-intercept-blood-system-at-the-39th-international-isbt-congress\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260617460945r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","datePublished":"2026-06-17T12:34:03+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cerus-to-showcase-new-evidence-innovation-and-global-experience-with-the-intercept-blood-system-at-the-39th-international-isbt-congress\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/cerus-to-showcase-new-evidence-innovation-and-global-experience-with-the-intercept-blood-system-at-the-39th-international-isbt-congress\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cerus-to-showcase-new-evidence-innovation-and-global-experience-with-the-intercept-blood-system-at-the-39th-international-isbt-congress\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260617460945r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260617460945r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cerus-to-showcase-new-evidence-innovation-and-global-experience-with-the-intercept-blood-system-at-the-39th-international-isbt-congress\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Cerus to Showcase New Evidence, Innovation and Global Experience with the INTERCEPT Blood System at the 39th International ISBT Congress"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/973104","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=973104"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/973104\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=973104"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=973104"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=973104"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}